{"id":"W2980301706","doi":"10.1182/blood.v120.21.800.800","title":"Long-Term Outcome of Ruxolitinib Treatment in Patients with Myelofibrosis: Durable Reductions in Spleen Volume, Improvements in Quality of Life, and Overall Survival Advantage in COMFORT-I","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Clinical endpoint; Internal medicine; Placebo; Randomized controlled trial; Quality of life (healthcare); Intention-to-treat analysis; Anemia; Surgery; Gastroenterology; Bone marrow; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008316499,0.0002619809,0.0008246526,0.0001046077,0.000196782,0.000316148,0.0001546406,0.0003124236,0.001206412],"category_scores_gemma":[0.0006084547,0.0001171644,0.0005799106,0.000178909,0.0002303683,0.0002999945,0.0002203133,0.0005406994,0.0001931181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003633101,"about_ca_system_score_gemma":0.000365655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002057153,"about_ca_topic_score_gemma":0.0006655126,"domain_scores_codex":[0.9997891,0.00008605939,0.00002487962,0.00003550471,0.00002623967,0.00003829183],"domain_scores_gemma":[0.9996235,0.00007118618,0.0001234684,0.00002800332,0.00001952221,0.0001343035],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5813089,0.01453342,0.1220163,0.0009305598,0.001459843,0.0006526033,0.0002903985,0.002803949,0.0617768,0.0002318552,0.003105797,0.2108896],"study_design_scores_gemma":[0.0670385,0.4805391,0.4353788,0.0001162198,0.001061417,0.001352942,0.0001945734,0.002776432,0.007951396,0.0002938567,0.003248742,0.00004807141],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986135,0.0007126008,0.00008768609,0.00005899977,0.000009606762,0.00005018686,0.0001343731,0.000005831538,0.0003272145],"genre_scores_gemma":[0.9990861,0.0001762285,0.0001448708,0.00007975586,0.00002623588,0.00006355939,0.0002692736,0.000001020774,0.0001529112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001206412,"threshold_uncertainty_score":0.004398227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02701392977540461,"score_gpt":0.3025728459730689,"score_spread":0.2755589161976643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}